Information Provided By: 
Fly News Breaks for October 19, 2015
CNC
Oct 19, 2015 | 07:59 EDT
Oppenheimer believes that "a lack of excitement" over Centene's (CNC) takeover of Health Net (HNT) is partly responsible for the recent decline in Centene's stock. The firm thinks the market is underestimating the potential of the Health Net deal, and predicts that Centene's EPS can reach $5 by 2017. Oppenheimer calls Centene's valuation "quite compelling." It keeps an $89 price target and Outperform rating on the shares.
News For CNC From the Last 2 Days
CNC
Apr 15, 2024 | 10:37 EDT
Shares of health care facilities and managed care are in the spotlight on Monday after Florida announced late on Friday five winners of six-year Medicaid managed care contracts. Among the winners... To see the rest of the story go to thefly.com. See Story Here
CNC
Apr 15, 2024 | 09:56 EDT
CNC
Apr 15, 2024 | 09:47 EDT
CNC
Apr 15, 2024 | 06:16 EDT
CNC
Apr 15, 2024 | 06:15 EDT
Wells Fargo raised the firm's price target on Centene (CNC) to $93 from $89 and keeps an Overweight rating on the shares. The firm notes Florida intends to award Medicaid contracts to Centene, Elevance Health (ELV), Humana (HUM) and two provider-run plans. Clearly the most positive for Centene given recent disappointing RFP performance and likely most disappointing for Molina Healthcare (MOH) given expectation for share gains, Wells says.
